






Since its implementation in 2015, the ​ASEAN Free               
Trade Area (AFTA) is a very strategic issue in creating                   
export opportunities for domestic products. One of the               
sectors that is the priority for ASEAN integration is                 
medical devices which are regulated in ​the ASEAN               
Medical Device Directive (AMDD) policy. This AMDD             
regulates standards, technical rules and conformity           
assessments in order to create a world trade system                 
that is increasingly open, free and competitive (ASEAN,               
2015). The better the quality of medical devices, the                 
better the competitiveness of medical devices in the               
global market ​[1,2]​. 
For Indonesia, the AMDD policy is quite an open                 
opportunity for various export activities of medical             
devices that have been produced and at the same time                   
a challenge to produce competitive medical devices in               
the ASEAN regional market. Efforts in this direction               
seem to require more serious action from the               
government, industry and the ​stakeholders involved.           
This is because in general Indonesian medical devices               
will continue to be faced with problems of low quality,                   
innovation and diversification of medical devices ​[3,4]​.             
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Abstract 
Purpose: ​Health care equipment international trade could serve a new          
strategic revenue for Indonesia. Since its implementation in 2015, AFTA has           
been a very strategic issue in creating export opportunities for its member            
countries. One of the sectors that becomes a priority for ASEAN integration is             
in the field of medical devices which is regulated in the ASEAN Medical             
Device Directive (AMDD) policy. Indonesia itself has officially ratified AMDD          
policy since 2018, but Indonesia will have been facing the problem of quality,             
innovation and diversification of medical devices. This study examines the          
competitiveness opportunities for domestic medical devices in ASEAN Free         
Trade Area. ​Method: This study used a qualitative method where          
information was obtained from in-depth interviews and document review.         
The informants came from policy makers, implementing officers, and         
stakeholders. ​Results: ​Indonesia has harmonized 26 out of 31 standards          
mandated by AMDD. Conformity assessment bodies in Indonesia that have          
been certified by the National Accreditation Committee have received         
international recognition. Indonesia has many potential exporting innovative        
medical devices to ASEAN countries. Fulfillment of medical devices is carried           
out through compulsory licensing and parallel import mechanism.        
Conclusion: Indonesia has a considerable opportunity in facing the ASEAN          
free market in the field of medical devices. AFTA is estimated to be able to               
meet the need for national medical devices in order to achieve a good             
degree of public health. 
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in medical device technologies is an important point in                 
international trade ​[5]​.  
Trade liberalization is expected to be able to               
improve regional public health status by increasing             
accessibility to medical devices. However, trade           
liberalization cannot be completely free because there             
are limitations related to the protection of intellectual               
property rights ​[6–8]​.  
Protection of intellectual property has been           
regulated internationally through ​Trade Related         
Aspects of Intellectual Property Rights ​(TRIPs) ​[7,9,10]​.             
In its development, there is considerable concern that               
the use of intellectual property rights by inventors can                 
cause economic justice problems and conflicts of             
interest which lead to global health problems ​[6,9]​. On                 
the one hand, intellectual property rights must be able                 
to provide incentives for the invention of medical               
devices. The basic principles of the ​World Trade               
Organization (WTO) stipulate that in international           
trade there should not be discrimination, especially             
regarding access to affordable medical devices ​[6]​.             
Therefore, in facing trade liberalization in ASEAN,             
Indonesia must have a policy to provide accessibility to                 
medical devices for ASEAN countries while still             
ensuring the sustainable development of the health             
system that has been built. 
One study showed that Indonesia's membership in             
AFTA did not have a significant impact on Indonesia's                 
agricultural exports, so it is necessary to formulate               
policies related to implementing economic         
globalization to produce agricultural commodities that           
are competitive internationally. Other studies also           
reveal that the use of ​preferential tariffs is only                 
concentrated on natural resource products, which           
causes a lack of export diversification. There is no                 
evidence that the reduction ​in preferential tariffs is able                 
to reduce the growth of imports from non-member               
countries ​[14]​.  
While studies on free trade and its impact on the                   
export position of Indonesian products have increased             
[11–13]​, there has been no research that discusses               
ASEAN free trade in medical devices which focuses on                 
non-tariff matters. This study wants to examine the               
opportunities for competitiveness of Indonesian         
medical devices in ASEAN free trade and whether               
AFTA is able to meet the needs of national medical                   
devices.  
METHODS 
This qualitative study collected data through           
in-depth interviews and document review. The           
informants were selected by ​purposive sampling using             
structured interviews, from August-September 2020 in           
several institutions implementing the AMDD: the           
Ministry of Health, the National Standardization           
Agency for Indonesia, the Ministry of Trade, the               
National Accreditation Committee for the Indonesian           
Medical Device Manufacturers Association (ASPAKI),         
Medical Device Manufacturers and the Conformity           
Assessment Institute.  
RESULTS 
Table 1 shows that of the 392 medical devices that                   
can be produced in Indonesia, the government has               
formulated 318 Indonesian National Standards (SNI)           
and 16 SNIs in the opinion poll stage. Based on the                     
results of interviews with informants, in the last two                 
years the Technical Committee for Standard           
Development has focused on reviewing existing           
standards.  
 
Table 1. Number of reference standards 
Source: List of SNI (National, 2020) (Penalkes, 2020)  
 
Table 2 shows that Indonesia has harmonized 26 of                 
the 31 standards mandated by AMDD.  
 
Table 2. List of medical device standards to be harmonized 
in ASEAN countries 
Source: Data on harmonized standards in ASEAN and a list of 
published SNIs (The ASEAN Secretariat, 2015) (National, 2020) 
 
Table 3 presents the composition of domestic             
medical devices based on risk class is: class A (3114                   
products), class B (3564 products), class C (926 products                 
and class D (21 products). 




SNIs That Have Been Issued  318 SNIs 
SNI in the Polling Stage  16 SNI  
Types of medical devices that 
alreadySNI  105 products 
Types of medical devices capable of 






IEC 60601-1, ISO/IEC 17011, ISO 13485, ISO 
14971, ISO 15223-1, ISO 11135, ISO 
11137-1, ISO 15190, ISO 11607-2, ISO 
14155, ISO 10993 series (17 part), ISO 





IEC 60601-1, ISO 13485,, ISO 15223-1, ISO 
11135 , ISO 11607-2, ISO 10993 series (17 





ISO/IEC 17011, ISO 14971, ISO 11137-1, ISO 
15190, ISO 14155 
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Source: List of Medical Device Info (Health, 2020) 
Table 4 informs the availability of a conformity               
assessment agency (LPK) for 28 test laboratories, 2               
equipment management system certification bodies, 29           
calibration laboratories and 3 certification bodies in             
Indonesia that have received accreditation from the             
National Accreditation Committee (KAN). The majority           
belong to the government. Medical Device Management             
System Certification Bodies (LSSMA) still involve           
auditors from abroad.   
 
Table 4. Number of conformity assessment bodies 
Source: Accredited Client Directory (National Accreditation 
Committee, 2020) 
 
Table 5 provides information that there are various               
types of medical devices that have great export               
opportunities to ASEAN countries because these           
products are innovative products of downstream           
research. 
 
Table 5.Potential medical devices for export to ASEAN 
countries 
 
Information was obtained that KAN has obtained             
international recognition for the laboratory         
accreditation system: Asia Pacific Laboratory         
Agreement Cooperation (APLAC), International       
Laboratory Accreditation Cooperation (ILAC), Mutual         
Recognition Agreement (MRA), inspection bodies         
within the APLAC and MRA and accreditation of               
institutions. quality and environmental management         
system certification in the PAC/IAF MLA (Multilateral             
Recognition Agreement). 
Table 6 shows changes in the average export of                 
medical devices per year before implementing the             
AMDD (2015-2018) are: Singapore (0.91%), Thailand           
(9.40%), Philippines (7.23%), Malaysia (6.36%), Vietnam           
(8.40%), Myanmar (107.29) Cambodia (88.27%), Brunei           
Darussalam (14.81%), Laos (0.98%) and the change of               
overall ASEAN countries (5.23%). From 2015-2019, the             
trend of medical devices export increased. Meanwhile,             
the value of changes in exports of medical devices to                   
ASEAN countries since the implementation of the             
AMDD (2018-2019) respectively as follows: Singapore           
(-4.66%), Thailand (11.51%), Philippines (6.32%),         
Malaysia (4,704%), Vietnam (-18,259%), Myanmar         
(-34.26%), Cambodia (15%), Brunei Darussalam (4.8%),           
















Test Laboratories 28 institutes 
Medical Device Management System 
Certification Bodies 2 institutes 
Calibration Laboratories 29 institutes 
Product Certification Bodies 3 institutes 
No  Type of Medical Devices 
1  Respiratory viral panel multiplex nucleic acid and             
assay 
2  Hepatitis A Virus (HAV) serological Assays 
3  Ultrasound and Muscle Stimulator 
5  Covid detection device through breath (in the test               
phase clinical) 
6  Water Powered Purifying Respirator 
7  Pedicle Screw 
8  Orthopedic implant 
9  Nasopharyngeal Cancer Early Detection Tool 
10  Machines anesthesia 
11  Picture archiving and communication systems 
14  Rapid test dengue testing 
15  Semilunar flushing valve system 
18  Electrocardiograph 
21  Absorbable hemostatic agent and dressing 
22  Impedance phlebograph 
23  Perinatal Monitoring System and Accessories 
24  Resorbable calcium salt bone void filler device 
25  Aqueous shunt 
26  Obstetric Gynecologic camera 


















Brunei Darussalam  14.81  4.86 
Laos  9.98  195.92 
ASEAN  5.23  -1.51 




Figure 1. Medical device export trends 2015-2019 (in USD) 
 
DISCUSSIONS 
The results show that the standard Indonesia's             
reference is still lacking. The number of SNIs has not                   
been able to keep up with the development of domestic                   
types of medical devices. This means that so far the                   
industry is still using a combination of SNI and                 
international standards as a reference in           
manufacturing products. Reference standards play a           
role in efforts to comply with regulations and as a                   
reference for the industry to ensure the safety, quality                 
and performance of medical devices ​[15,16]​. The             
shortage of existing standards is partly due to the fact                   
that the Technical Committee for the formulation of               
standards in the last two years has focused on                 
reviewing irrelevant standards stipulated in Regulation           
of the National Standardization Agency for Indonesia             
No. 6 of 2018 concerning SNI Review Guidelines ​[17]​.                 
Therefore, the improvement of the medical device             
standardization system is to improve quality control             
and encourage the development of the medical device               
industry ​[18]​.  
Judging from the standards mandated by the AMDD               
to be harmonized by member countries, Indonesia has               
harmonized most of these standards into SNI.             
Standards that have not been harmonized into SNI are                 
standards related to risk class D medical devices. This                 
means that Indonesia has been able to penetrate the                 
ASEAN market for low and medium risk medical               
devices. This is because standards have a role as a                   
reference for shaping trade equality so as to minimize                 
global trade imbalances ​[5]​. Even though it has only                 
harmonized 26 of the 31standards AMDD, Indonesia             
actually has quite a big opportunity to export medical                 
devices. This can be seen from the composition of risk                   
class A, B and C medical devices more than 99% ​[19]​. If                       
this opportunity is utilized properly, it is very possible                 
that market share ASEAN'scan be owned by Indonesia.  
LPK or what is often referred to as a notified body,                     
is an institution that is very important in ensuring the                   
quality of medical device products. This LPK has a                 
function to check the compliance of medical devices to                 
predetermined standards through testing, certification         
and inspection ​[20,21]​. Just like in other countries, LPK                 
in Indonesia are appointed and supervised by an               
agency authorized by the government, namely KAN             
[22]​. KAN is appointed by the President and is                 
responsible to the President through the Head of BSN                 
[23]​. With the international recognition that has been               
obtained by KAN, it means that the test certificate                 
issued by the LPK can be used as a condition for                     
exporting medical devices abroad. So that when             
entering ASEAN countries, these medical devices no             
longer need to be retested.  
Based on the research results, the number of LPK is                     
still very low. One of the reasons for this lack of LPK is                         
the lack of private sector involvement in the provision                 
of LPK. The lack of private sector involvement in LPK                   
provision makes conformity assessment less         
competitive in terms of both time and service costs. The                   
lack of availability of LPK, especially test laboratories,               
can cause the industry to conduct product testing               
abroad which requires greater costs. Test costs can               
affect the cost of production of medical devices which                 
can cause the price of medical devices to be high ​[22]​.                     
Furthermore, it can affect the competitiveness of             
domestic medical devices. 
In addition, the most important thing in the               
competitiveness of this medical device is the fulfillment               
of ISO 13485 which is certified by LSSMA. ISO 13485                   
certification is very important to ensure that the               
medical device industry management system meets the             
standards ​[24]​. In Indonesia currently there are only               
two institutions LSSMA and involve auditors from             
abroad. This means, so far the industry has also                 
involved LSSMA from abroad to carry out testing,               
certification and inspection of medical device           
management systems. 
Through the innovation of medical devices it can be                 
seen that there is a serious effort to provide better                   
medical devices in terms of diversity, safety and               
effectiveness ​[25]​. In order to protect Intellectual             
Property Rights (HKI) in the field of medical devices,                 
the government provides that it has ratified the TRIPS                 
(​The Agreement on Trade-Related Aspects of Intellectual             
Property Rights​) into Law Number 13 of 2016               
concerning Patents and Law Number 28 of 2014               
concerning copy rights ​[26]​. Particularly in the health               
sector, Indonesia has issued several policies related to               
the regulation of Intellectual Property Rights (IPR) as               
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outlined in the Health Minister's Decree Number             
1179A/Menkes/SK/X/1999 concerning the National       
Policy for Research and Development of IPR,             
Balitbangkes Strategic Plan 2010-2014 which stated that             
one of the main indicators in research and               
development of medical devices is the acquisition of               
IPR ​[26]​. This IPR policy regulates incentives for               
medical device innovators. 
In facing the challenges of global public health               
problems as a form of IPR protection, the fulfillment of                   
medical devices is carried out through several             
mechanisms, namely compulsory licensing and parallel           
imports ​[27]​. The compulsory license allows Indonesia             
as a developing country to import ​licensed medical               
devices from patented medical devices. Meanwhile,           
parallel imports can be done by importing from other                 
countries that have been licensed by the inventor ​[27]​.                 
However, this policy has not been described in detail in                   
the IPR policy in Indonesia.  
Export data shows that since 2015, 9 ASEAN               
countries have annually imported medical devices           
from Indonesia, especially from Singapore and           
Thailand. This shows that Indonesian medical devices             
meet the quality requirements for entry into ASEAN               
countries. When viewed from the change in the               
average export per year, before the implementation of               
AMDD in 2015-2018, it increased by 5.23%. Meanwhile,               
after the implementation of AMDD in 2018-2019, there               
was a decrease of 1.51%. Based on these data, it cannot                     
be concluded whether thepolicy AMDD has a positive               
or negative impact on the export of medical devices.                 
This is because the AMDD has only lasted 2 years, and                     
data collection has only been carried out until 2019.                 
Based on the results of research conducted by previous                 
researchers, the AFTA arrangement has a positive             
impact on manufacturing trade ​[28]​.  
The increase in exports of medical devices is not                 
only influenced by the implementation of AMDD, but               
also by ​supply and ​demand factors​. An increase or                 
decrease in ASEAN free trade can also occur due to the                     
large number of product choices for importing             
countries, so that the ​market share of exporting               
countries ​existing decreases ​[11]​. When viewed from             
the available data, the potential for medical device               
exports is expected to continue to grow, given that                 
Indonesia is geographically closer to ASEAN countries             
than Europe and America, which are known as the                 
leader of medical devices in the world. This geographic                 
location is often a barrier to trade because of the high                     
distribution costs that can affect product prices ​[11,29]​.               
If this potential is utilized properly, Indonesia can               
achieve medical device independence and gain an             
economic impact in the trade sector ​[30,31]​.  
CONCLUSION  
Indonesia has a considerable opportunity in facing             
the ASEAN free market in the field of medical devices.                   
AFTA is estimated to be able to meet the need for                     
national medical devices in order to achieve a good                 
degree of public health. 
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